Axogen rises after Q1 revenue beat estimates

AxoGen

28/04/2026 12:55

** Shares of surgical device maker Axogen AXGN.O rise 9.9% to $43.44 premarket

** AXGN posts Q1 revenue of $61.5 mln, beating analysts' estimates of $57.7 mln, according to data compiled by LSEG

* It now expects 2026 revenue growth to be at least 20%, or $270 mln, compared with prior forecast of 18% or $265.7 mln

** Analysts on an average were expecting annual revenue to be $266.2 mln

** As of March 31, cash and cash equivalents, restricted cash, and investments was $103.6 mln, as compared to $45.5 mln as of December 31, 2025 - AXGN

** As of last close, stock up 20.4% YTD

 (Reporting by Siddhi Mahatole)

 ((siddhi.mahatole@thomsonreuters.com))